TobaccoReporter logo

Category: Business & Finance

  • PMI Reduces Zyn Production in Owensboro

    PMI Reduces Zyn Production in Owensboro

    Philip Morris International announced it will scale back production at its Swedish Match facility in Owensboro, Kentucky, shifting part of its Zyn nicotine pouch operations from a 24/7 schedule to a 24/5 schedule beginning in early July, according to The Owensboro Times. The adjustment primarily affects the Zyn Flagship department, which will return to a five-day, three-shift model under the terms of the existing collective bargaining agreement.

    The company said the move reflects changing market conditions, with production currently exceeding demand following a period of rapid growth and capacity expansion. PMI invested more than $230 million into the Owensboro site in 2024, increasing output and adding approximately 450 jobs to support strong demand for Zyn products.

    PMI emphasized that the change is a production realignment rather than a reduction in long-term commitment to the facility, noting that other operations, including Zyn Ultra production and maintenance, will remain on a 24/7 schedule. The company said it will work with union leadership on staffing adjustments and indicated the schedule could return to continuous operations if demand increases.

  • PMI Expands Ducati Partnership to Promote Zyn

    PMI Expands Ducati Partnership to Promote Zyn

    Philip Morris International expanded its long-standing partnership with Ducati Corse, announcing that its Zyn nicotine pouch brand will be featured on MotoGP race liveries at select events starting in the 2026 season. The move marks a new phase in the collaboration, which dates back to 2003, and reflects PMI’s continued focus on promoting smoke-free products through high-profile global platforms.

    PMI said the partnership aligns with its broader strategy to grow its oral nicotine portfolio, with ZYN positioned as a key driver in the company’s transition away from cigarettes. Ducati said the renewed agreement builds on a shared emphasis on innovation and performance, as both organizations look to extend their presence and engagement with adult consumers in international markets.

  • FDA Issues NSE Orders for Seneca’s 28 Cigarette Products

    FDA Issues NSE Orders for Seneca’s 28 Cigarette Products

    Today (March 23), the U.S. Food and Drug Administration issued Not Substantially Equivalent (NSE) orders for 28 cigarette products manufactured by Seneca Manufacturing Company, determining they do not meet the legal standard to remain on the market. As a result, these products, sold under the Heron and Sands brands, can no longer be distributed, imported, marketed, or sold in the United States.

    The affected products were previously allowed to remain on the market under provisional substantial equivalence status while under FDA review. With the final NSE determinations now posted, retailers have been instructed to coordinate with manufacturers or suppliers to remove remaining inventory.

    The agency said it will exercise enforcement discretion until May 23, after which non-compliant sales could face penalties. FDA noted that enforcement actions may include warning letters, fines, product seizures, or injunctions. The agency also pointed retailers to its searchable tobacco products database, which lists authorized products eligible for legal sale, as part of ongoing efforts to support compliance with federal tobacco regulations.

    Seneca Manufacturing Company is a tobacco manufacturer founded in 2006 after obtaining its federal TTB license, initially operating with a small team and focusing distribution within Seneca Nation territory in the New York area before expanding to multiple U.S. states and other Indigenous markets.

  • Al Fakher Owner Moves Ahead with Nasdaq Listing

    Al Fakher Owner Moves Ahead with Nasdaq Listing

    Advanced Inhalation Rituals (AIR), the Dubai-based owner of hookah tobacco brand Al Fakher, is proceeding with plans to go public on Nasdaq through a merger with Cantor Equity Partners III, with the deal potentially closing in early May. The company recently submitted its second filing to the U.S. Securities and Exchange Commission, and if approved, the transaction—valuing the combined entity at approximately $1.75 billion—will move to a shareholder vote.

    “The SEC’s declaration of effectiveness of our registration statement is an important regulatory milestone in our journey to become a public company,” said AIR CEO Stuart Brazier, “and we look forward to our planned debut on the Nasdaq as a pure-play social inhalation leader in the coming months.”

    AIR reported 2025 net revenue of $400 million, up 6% year over year, with profits rising to $47 million. The company serves around 14 million consumers globally and operates across 90 markets, with manufacturing facilities spanning the Middle East and Europe. Growth remains driven by expansion in markets such as the U.S., Europe, and Saudi Arabia.

    While operations have not been directly impacted by the ongoing Middle East conflict, supply chains have faced disruption due to the closure of the Strait of Hormuz, increasing logistics costs. The company said it has rerouted shipments and is working to offset higher expenses through cost controls and selective price adjustments, while maintaining its outlook for continued growth in 2026.

  • PMI Q1 Results Driven by Smoke-Free Growth

    PMI Q1 Results Driven by Smoke-Free Growth

    Philip Morris International reported first-quarter 2026 net revenues of $10.1 billion, up 9.1%, with adjusted diluted EPS rising 16% to $1.96 despite a decline in reported EPS due to a non-cash adjustment. Growth was driven primarily by the company’s smoke-free portfolio, which now accounts for 43% of total revenue and is available in more than 100 markets.

    The smoke-free segment delivered strong performance, with revenue increasing 24.7% and shipment volumes up 11.9%. IQOS remained the key growth driver, with double-digit gains and expanding market share, including becoming the top nicotine brand in markets where it is present. E-vapor products also showed rapid growth, while nicotine pouch volumes expanded in several markets despite declines in Nordic snus.

    Combustible cigarette volumes declined 5.1% in the quarter, although pricing supported modest revenue growth in the segment. Looking ahead, PMI expects continued momentum in smoke-free products, forecasting adjusted EPS growth of 10.9% to 12.9% for 2026 and organic revenue growth of 5% to 7%, supported by ongoing investment in its reduced-risk portfolio.

  • PMI Partners IQOS with Devialet at Milan Design Week

    PMI Partners IQOS with Devialet at Milan Design Week

    Philip Morris International announced a collaboration between its IQOS heated tobacco brand and French audio company Devialet, featuring an exhibition at Milan Design Week 2026. The installation runs from April 20–27 and includes a co-branded limited-edition product pairing an IQOS device with Devialet earbuds.

    “The sound waves carry a signature rhythm – a pattern as unique as a fingerprint,” said Oggie Kapetanovic, president of the Heat Not Burn division at PMI. “Devialet’s sound waves turn emotion into shared experience; IQOS empowers self‑expression while connecting a community of over 35 million users.”

  • KT&G to Cancel $1.3B Treasury Shares

    KT&G to Cancel $1.3B Treasury Shares

    KT&G announced it will cancel all 10.9 million treasury shares it holds, valued at approximately 1.85 trillion won ($1.3 billion), with the burn scheduled for April 23. The decision, approved by the board, follows recent changes to Korea’s commercial law and is aimed at enhancing shareholder value.

    The move aligns with the company’s broader capital return strategy, which also includes raising its annual dividend to 6,000 won ($4.08) per share.

  • NACS Urges Action Against Illicit Chinese Vapes

    NACS Urges Action Against Illicit Chinese Vapes

    The National Association of Convenience Stores (NACS) called on U.S. trade officials to address the surge of illicit e-cigarettes entering the country from China, warning that unauthorized products now account for an estimated 80% of the ENDS market. In a submission to the U.S. Trade Representative, NACS said these imports, which often lack FDA authorization, pose health risks, particularly to youth, while undermining compliant retailers and legitimate supply chains.

    NACS is urging a coordinated government response, including enforceable commitments from China to restrict exports that violate U.S. regulations, improve product classification and oversight, and strengthen enforcement mechanisms. The group said curbing illicit flows is critical to protecting public health, ensuring fair competition, and safeguarding the economic viability of regulated businesses.

  • Altria to Host Q1 Webcast April 30

    Altria to Host Q1 Webcast April 30

    Altria Group, Inc. announced it will host a live audio webcast on April 30 at 9 a.m. EST to discuss its 2026 first-quarter business results, and plans to issue a press release containing its business results two hours earlier. The webcast can be accessed at altria.com.

    During the webcast, Billy Gifford, Altria’s Chief Executive Officer, and Sal Mancuso, Altria’s Chief Financial Officer, will discuss the Company’s 2026 first-quarter business results and answer questions from the investment community and news media.

    The webcast will be in a listen-only mode. Pre-event registration is necessary; directions are posted at www.altria.com/webcasts. An archived copy of the webcast will be available on altria.com.

  • Organigram Completes Sanity Acquisition with BAT Backing

    Organigram Completes Sanity Acquisition with BAT Backing

    Organigram Global and Sanity Group jointly announced the official closing of Organigram’s acquisition of the Germany-based cannabis company that was originally announced in February. Combining cash and shares as part of its international expansion strategy, the deal is valued at €107.3 million. The transaction was supported by €40.3 million in new financing from British American Tobacco and additional credit facilities, highlighting BAT’s continued backing of Organigram’s growth initiatives. The deal marks the final deployment of funds from the Jupiter strategic investment pool and strengthens Organigram’s position in the European cannabis market.